FDA Approves Natpara (parathyroid hormone) for Hypocalcemia in Patients with Hypoparathyroidism

January 23, 2015 — The U.S. Food and Drug Administration today approved Natpara (parathyroid hormone) to control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism, a rare disease that affects approximately 60,000 people in…
Drugs.com – New Drug Approvals

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us